Skip to main content
. 2023 Jul 21;12(14):4827. doi: 10.3390/jcm12144827
JAKi Janus kinase inhibitors
RA Rheumatoid arthritis
ALC Absolute lymphocyte count
DAS28 the disease activity score of 28 joints
CRP C-reactive protein
ESR erythrocyte sedimentation rate
CDAI Clinical Disease Activity Index
AEs adverse events
ACR American College of Rheumatology
ACPA anti-citrullinated protein/peptide antibody
MACE major adverse cardiovascular events
MTX methotrexate
bDMARD Biological disease-modifying antirheumatic drug.
CVD cardiovascular disease